reports
Grand Design RV is Giving Away a Summer of Free Camping
Grand Design RV is Giving Away a Summer of Free Camping Winner will kick-off summer with a glamping-inspired getaway to New York City and campsite experiences sponsored by Grand Design RV all summer long MIDDLEBURY, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- To celebrate the , Grand Design RV, a wholly owned subsidiary of Winnebago Industries (NYSE: WGO) and one of the fastest-growing RV brands known for its top-of-the-line recreational vehicles, is bringing camping to the heart of New York City this summer by offering one lucky winner the Ultimate Glamping Getaway Weekend, plus a summer fi...
XWELL, Inc. Reports First Quarter 2024 Results
XWELL, Inc. Reports First Quarter 2024 Results NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024. Recent Highlights: XWELL delivered 2024 first quarter revenue growth of approximately 24% from the 2023 first quarter.The Company has reduced its cost structure, simplified its processes, and has maintained continued momentum on its path to profitability. The following demonstrates the positive effects of XWELL’s actions ...
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
Elevai Labs Inc. Reports First Quarter 2024 Financial Results NEWPORT BEACH, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, today reported financial results for the first quarter ended March 31, 2024. Elevai Labs CEO, Jordan R. Plews, PhD stated, "This quarter, Elevai Labs has demonstrated remarkable year-over-year revenue growth while significantly improving our gross margin, reflecting our commitment to optimizing production and stringent cost management. We remain focused on sustainable gr...
Digital Media Solutions, Inc. Announces Q1 2024 Financial Results
Digital Media Solutions, Inc. Announces Q1 2024 Financial Results First-quarter net revenue of $70.7 millionFirst-quarter gross margin of 20.2% and Variable Marketing Margin (VMM) of 23.7% CLEARWATER, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- Digital Media Solutions, Inc., (OTCMKTS: DMSL) (“DMS” or the “Company”), a leading provider of technology-enabled digital performance advertising solutions connecting consumers and advertisers, today announced financial results for the first quarter ended March 31, 2024. DMS serves over 315 scaled enterprise customers and approximately 4,550 small and...
ISS, an Independent Proxy Solicitation Firm, Recommends Voting “FOR” E...
CENTENNIAL, Colo.--(BUSINESS WIRE)-- Westwater Resources, Inc. (NYSE American: WWR) an energy technology and battery-grade natural graphite development company, today announced that an independent proxy solicitation firm – Institutional Shareholder Services Inc. (“ISS”) – has recommended voting “FOR” each of the five proposals pending before the shareholders at Westwater’s 2024 Annual Meeting (“Annual Meeting”) scheduled for May 30, 2024. As detailed in the proxy statement filed on April 5, 2024 for the Annual Meeting, there are five proposals that are being presented to Westwater’s sharehol...
FSI ANNOUNCES FIRST QUARTER, 2024 FINANCIAL RESULTS
FSI ANNOUNCES FIRST QUARTER, 2024 FINANCIAL RESULTS A CONFERENCE CALL IS SCHEDULED FOR THURSDAY, MAY 16, 2024, 11:00AM EASTERN TIME SEE DIAL IN NUMBER BELOW VICTORIA, BRITISH COLUMBIA, May 15, 2024 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE Amex: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. Today the C...
Elicio Therapeutics Reports First Quarter 2024 Financial Results and P...
Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates ELI-002 2P Phase 1 preliminary data published in Nature Medicine ELI-002 2P Phase 1 data characterizing the CD4 and CD8 profile of the KRAS immune response and ELI-002-generated antigen spreading presented at the AACR Annual MeetingELI-002 7P Phase 1 preliminary data to be presented at the ASCO Annual Meeting (“ASCO”) in June 2024ELI-002 7P randomized Phase 2 trial enrollment expected to complete in fourth quarter 2024 BOSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq:...
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Resu...
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results Conference Call Scheduled for today, May 15, 2024, at 5:00pm ET GARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024. Q3 2024 Financial Highlights (3 Months Ended March 31, 2024): Revenue increased 4% to $5.2 million, compared to $5.0 mi...
Morgan Stanley Declares Dividends on Its Preferred Stock
NEW YORK--(BUSINESS WIRE)-- Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $397.50 per share (equivalent to $0.397504 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $450.26 per share (equivalent to $0.450260 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $434.46 per share (equ...
FibroBiologics Announces 2024 Annual Meeting of Stockholders
FibroBiologics Announces 2024 Annual Meeting of Stockholders HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that its 2024 Annual Meeting of Stockholders will take place on August 27, 2024, at 11 a.m. CDT, exclusively through a virtual format. The record date for determination of stockholders entitled to vote a...
DallasNews Corporation Announces First Quarter 2024 Financial Results
DallasNews Corporation Announces First Quarter 2024 Financial Results DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company”) today reported a first quarter 2024 net loss of $1.4 million, or $(0.25) per share, and an operating loss of $1.8 million. In the first quarter of 2023, the Company reported a net loss of $2.6 million, or $(0.49) per share, and an operating loss of $2.8 million. For the first quarter of 2024, on a non-GAAP basis, DallasNews reported an operating loss adjusted for certain items (“adjusted operating loss”) of $0.8 milli...
Interpublic Group to Present at the 52nd Annual J.P. Morgan Global Tec...
Interpublic Group to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference New York, NY, May 15, 2024 (GLOBE NEWSWIRE) -- (NYSE: IPG) senior management will present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference on Monday, May 20th, 2024, at 10:00 am Eastern time, as scheduled. A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic's website () where it will remain available for replay for 30 days. # # # About InterpublicInterpubli...
Lantheus Announces Executive Appointments to Accelerate Innovation
Lantheus Announces Executive Appointments to Accelerate Innovation Jeffrey S. Humphrey, MD appointed Chief Medical Officer;Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Science Officer (CSO), effecti...
NeurAxis to Host First Quarter 2024 Results and Business Update Call o...
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024 CARMEL, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its first quarter 2024, for the period ended March 31, 2024, on Wednesday, May 22, 2024, before market open. The Company has scheduled a conference call for the same day, Wednesday, May 22, 2024, ...
Alstom SA: 2023/24 Universal Registration Document available
Alstom SA: 2023/24 Universal Registration Document available 15 May 2024 – Alstom's 2023/24 Universal Registration Document, which includes notably the Annual Financial Report, was filed with the "Autorité des marchés financiers" (AMF) on 15 May 2024. This document is available to the public free of charge in accordance with applicable regulation and may be viewed on Alstom's website (, as well as on the AMF website (-france.org).The following information is included in the 2023/24 Universal Registration Document:•the Annual Financial Report, including notably the consolidated financial sta...
- ABGSC Shipping & Transport Research
- Oliver Dunvold
- Petter Haugen
- ABGSC Financials Research
- Fredrik Flørnes Støle
- Jan Erik Gjerland
Moody's Ratings affirms Ba2 on Cumberland Academy, TX; stable outlook
Moody's Ratings (Moody's) has affirmed the Ba2 rating for Cumberland Academy, TX. The affirmation impacts the school's Series 2020A Education Revenue Bonds. These bonds are the school's only outstanding debt, and roughly $75 million remains outstanding. The outlook is stable. RATINGS RATIONALE T...
Uniti Group Inc. to Participate at the J.P. Morgan 52nd Annual Global ...
Uniti Group Inc. to Participate at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference LITTLE ROCK, Ark., May 15, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference on May 22, 2024 in Boston, MA. Any investor materials will be made available on Uniti’s Investor Relations website at u...
Cidara Therapeutics Provides Corporate Update and Reports First Quarte...
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline. “Our reacquisition of our CD388 progr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.